Frank X. Leonard, Chief Executive Officer at NovoCure Ltd (NVCR), sold 5,607 shares at $13.31 ($75K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Seasonal sale ($75k) by Chief Executive Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $552K | — | Filing → |